ProPhase Labs (PRPH)
(Delayed Data from NSDQ)
$5.42 USD
+0.11 (2.07%)
Updated May 3, 2024 04:00 PM ET
After-Market: $5.46 +0.04 (0.74%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: BMO |
3/2024 | $-0.28 | 46.43% |
Earnings Summary
For their last quarter, ProPhase Labs (PRPH) reported earnings of -$0.51 per share, missing the Zacks Consensus Estimate of -$0.26 per share. This reflects a negative earnings surprise of 96.15%. Look out for PRPH's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.28 per share, reflecting a year-over-year decrease of 1033.33%.
Earnings History
Price & Consensus
Zacks News for PRPH
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
PRPH: What are Zacks experts saying now?
Zacks Private Portfolio Services